<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>Clinical Chemistry via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Clinical Chemistry' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Clinical+Chemistry&t=Clinical+Chemistry&s=Search&f=source]]></link>
        <lastBuildDate>Thu, 09 Feb 2012 13:01:33 +0100</lastBuildDate>
        <item>
            <title>American Old Master: The Art and Science of Thomas Eakins [Science in the Arts]</title>
            <link>http://www.medworm.com/index.php?rid=5643310&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F2%2F480%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643310</comments>
            <pubDate>Sat, 28 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643310</guid>        </item>
        <item>
            <title>Diary [Unveiling the Right Side]</title>
            <link>http://www.medworm.com/index.php?rid=5643309&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F2%2F479%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643309</comments>
            <pubDate>Sat, 28 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643309</guid>        </item>
        <item>
            <title>Sinusitis or Something Worse? [What is your Guess?]</title>
            <link>http://www.medworm.com/index.php?rid=5643308&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F2%2F477%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643308</comments>
            <pubDate>Sat, 28 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643308</guid>        </item>
        <item>
            <title>Correction [Correction]</title>
            <link>http://www.medworm.com/index.php?rid=5643307&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F2%2F476%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643307</comments>
            <pubDate>Sat, 28 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643307</guid>        </item>
        <item>
            <title>In Reply [Letters to the Editor]</title>
            <link>http://www.medworm.com/index.php?rid=5643306&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F2%2F474%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643306</comments>
            <pubDate>Sat, 28 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643306</guid>        </item>
        <item>
            <title>Do Platform-Specific Factors Explain MicroRNA Profiling Disparities? [Letters to the Editor]</title>
            <link>http://www.medworm.com/index.php?rid=5643305&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F2%2F472%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643305</comments>
            <pubDate>Sat, 28 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643305</guid>        </item>
        <item>
            <title>Impact of the Introduction of Guidelines on Vitamin B12 Testing [Letters to the Editor]</title>
            <link>http://www.medworm.com/index.php?rid=5643304&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F2%2F471%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643304</comments>
            <pubDate>Sat, 28 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643304</guid>        </item>
        <item>
            <title>Brain Natriuretic Peptide and Breathing Not Properly: The Merger of 2 BNPs [Citation Classic]</title>
            <link>http://www.medworm.com/index.php?rid=5643303&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F2%2F469%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643303</comments>
            <pubDate>Sat, 28 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643303</guid>        </item>
        <item>
            <title>Further Improvement in Quantifying Male Fetal DNA in Maternal Plasma [Brief Communication]</title>
            <link>http://www.medworm.com/index.php?rid=5643302&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F2%2F465%3Frss%3D1</link>
            <description>CONCLUSIONS:
The YRS assay is a substantial improvement for quantifying rare male fetal DNA in maternal plasma. The higher sensitivity and specificity may expand the clinical and research utility of cffDNA. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643302</comments>
            <pubDate>Sat, 28 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643302</guid>        </item>
        <item>
            <title>Comparison of Serum Creatinine and Cystatin C for Early Diagnosis of Contrast-Induced Nephropathy after Coronary Angiography and Interventions [Evidence-Based Medicine and Test Utilization]</title>
            <link>http://www.medworm.com/index.php?rid=5643301&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F2%2F458%3Frss%3D1</link>
            <description>CONCLUSIONS:
Variations from the serum creatinine baseline offer better diagnostic accuracy for predicting CIN at an earlier stage than similar variations in Cys. An additional diagnostic value of Cys over the determination of serum creatinine in the setting of CIN was not observed. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643301</comments>
            <pubDate>Sat, 28 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643301</guid>        </item>
        <item>
            <title>Estimating Glomerular Filtration Rates by Use of Both Cystatin C and Standardized Serum Creatinine Avoids Ethnicity Coefficients in Asian Patients with Chronic Kidney Disease [Evidence-Based Medicine and Test Utilization]</title>
            <link>http://www.medworm.com/index.php?rid=5643300&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F2%2F450%3Frss%3D1</link>
            <description>CONCLUSIONS:
The use of a cystatin C and creatinine combination equation for estimating GFR in a multiethnic Asian population with CKD does not require ethnicity coefficients because the derived coefficients are very close to each other. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643300</comments>
            <pubDate>Sat, 28 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643300</guid>        </item>
        <item>
            <title>Growth Differentiation Factor-15 in the Early Diagnosis and Risk Stratification of Patients with Acute Chest Pain [Proteomics and Protein Markers]</title>
            <link>http://www.medworm.com/index.php?rid=5643299&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F2%2F441%3Frss%3D1</link>
            <description>CONCLUSIONS:
GDF-15 predicts all-cause mortality in unselected patients with acute chest pain independently of and more accurately than hs-cTnT and BNP. However, GDF-15 does not seem to help in the early diagnosis of AMI. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643299</comments>
            <pubDate>Sat, 28 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643299</guid>        </item>
        <item>
            <title>Exhaled Endogenous Particles Contain Lung Proteins [Proteomics and Protein Markers]</title>
            <link>http://www.medworm.com/index.php?rid=5643298&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F2%2F431%3Frss%3D1</link>
            <description>CONCLUSIONS:
Our data strongly support that PEx originate from RTLF and reflect the composition of undiluted RTLF. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643298</comments>
            <pubDate>Sat, 28 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643298</guid>        </item>
        <item>
            <title>Junction Site Analysis of Chimeric CYP21A1P/CYP21A2 Genes in 21-Hydroxylase Deficiency [Molecular Diagnostics and Genetics]</title>
            <link>http://www.medworm.com/index.php?rid=5643297&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F2%2F421%3Frss%3D1</link>
            <description>CONCLUSIONS:
Junction site analysis can explain some genotype&amp;ndash;phenotype discrepancies. Sequencing the well-established CYP779f/Tena32F amplicons is an unequivocal strategy for detecting attenuated chimeric CYP21A1P/CYP21A2 genes, which are clinically relevant. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643297</comments>
            <pubDate>Sat, 28 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643297</guid>        </item>
        <item>
            <title>Circulating Soluble Intercellular Adhesion Molecule 1 and Subclinical Atherosclerosis: the Coronary Artery Risk Development in Young Adults Study [Lipids, Lipoproteins, and Cardiovascular Risk Factors]</title>
            <link>http://www.medworm.com/index.php?rid=5643296&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F2%2F411%3Frss%3D1</link>
            <description>CONCLUSIONS:
sICAM-1 concentration may be an early biomarker that indicates changes in the artery wall that accompany atherosclerosis, as well as the presence of advanced plaque in the coronary and carotid arteries. This finding holds in people with low total burden of atherosclerosis, decades before the development of clinical CVD. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643296</comments>
            <pubDate>Sat, 28 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643296</guid>        </item>
        <item>
            <title>Kinetic Modeling of Storage Effects on Biomarkers Related to B Vitamin Status and One-Carbon Metabolism [General Clinical Chemistry]</title>
            <link>http://www.medworm.com/index.php?rid=5643295&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F2%2F402%3Frss%3D1</link>
            <description>CONCLUSIONS:
Data on stability and deterioration kinetics for individual biomarkers are required to optimize procedures for handling serum and plasma, and for addressing preanalytical bias in epidemiological and clinical studies. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643295</comments>
            <pubDate>Sat, 28 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643295</guid>        </item>
        <item>
            <title>Specificity Characteristics of 7 Commercial Creatinine Measurement Procedures by Enzymatic and Jaffe Method Principles [General Clinical Chemistry]</title>
            <link>http://www.medworm.com/index.php?rid=5643294&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F2%2F391%3Frss%3D1</link>
            <description>CONCLUSIONS:
There were differences in both magnitude and direction of bias among measurement procedures, whether enzymatic or Jaffe. The influence of interfering substances was less frequent with the enzymatic procedures, but no procedure was unaffected. The details of implementation of a method principle influenced its susceptibility to potential interfering substances. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643294</comments>
            <pubDate>Sat, 28 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643294</guid>        </item>
        <item>
            <title>Aptameric Molecular Switch for Cascade Signal Amplification [Automation and Analytical Techniques]</title>
            <link>http://www.medworm.com/index.php?rid=5643293&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F2%2F384%3Frss%3D1</link>
            <description>CONCLUSIONS:
The aptameric sensor provides promising potential for detecting and screening trace concentrations of biomarkers in complex matrices for clinical applications. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643293</comments>
            <pubDate>Sat, 28 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643293</guid>        </item>
        <item>
            <title>Quantification of Methylated Markers with a Multiplex Methylation-Specific Technology [Cancer Diagnostics]</title>
            <link>http://www.medworm.com/index.php?rid=5643292&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F2%2F375%3Frss%3D1</link>
            <description>CONCLUSIONS:
The QuARTS technology provides a promising approach for quantifying methylated markers. The markers assayed highly discriminated colorectal neoplasia from healthy epithelia. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643292</comments>
            <pubDate>Sat, 28 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643292</guid>        </item>
        <item>
            <title>Multiplex Immunoassays of Peptide Hormones Extracted from Formalin-Fixed, Paraffin-Embedded Tissue Accurately Subclassify Pituitary Adenomas [Cancer Diagnostics]</title>
            <link>http://www.medworm.com/index.php?rid=5643291&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F2%2F366%3Frss%3D1</link>
            <description>CONCLUSIONS:
Multiplex immunoassays performed on FFPE tissue extracts can provide diagnostically relevant information and may exceed the performance of IHC in classifying some pituitary neoplasms. This technique is simple, largely amenable to automation, and likely applicable to other diagnostic problems in molecular pathology. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643291</comments>
            <pubDate>Sat, 28 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643291</guid>        </item>
        <item>
            <title>Searching for New Biomarkers of Renal Diseases through Proteomics [Reviews]</title>
            <link>http://www.medworm.com/index.php?rid=5643290&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F2%2F353%3Frss%3D1</link>
            <description>BACKGROUND:
Technological advances have resulted in a renaissance of proteomic studies directed at finding markers of disease progression, diagnosis, or responsiveness to therapy. Renal diseases are ideally suited for such research, given that urine is an easily accessible biofluid and its protein content is derived mainly from the kidney. Current renal prognostic markers have limited value, and renal biopsy remains the sole method for establishing a diagnosis. Mass spectrometry instruments, which can detect thousands of proteins at nanomolar (or even femtomolar) concentrations, may be expected to allow the discovery of improved markers of progression, diagnosis, or treatment responsiveness.

CONTENT:
In this review we describe the strengths and limitations of proteomic methods and the dra...</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643290</comments>
            <pubDate>Sat, 28 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643290</guid>        </item>
        <item>
            <title>Fetal Laboratory Medicine: On the Frontier of Maternal-Fetal Medicine [Reviews]</title>
            <link>http://www.medworm.com/index.php?rid=5643289&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F2%2F337%3Frss%3D1</link>
            <description>BACKGROUND:
Emerging antenatal interventions and care delivery to the fetus require diagnostic support, including laboratory technologies, appropriate methodologies, establishment of special algorithms, and interpretative guidelines for clinical decision-making.

CONTENT:
Fetal diagnostic and therapeutic interventions vary in invasiveness and are associated with a spectrum of risks and benefits. Fetal laboratory assessments are well served by miniaturized diagnostic methods for blood analysis. Expedited turnaround times are mandatory to support invasive interventions such as cordocentesis and intrauterine transfusions. Health-associated reference intervals are required for fetal test interpretation. Fetal blood sampling by cordocentesis carries substantial risk and is therefore performed o...</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643289</comments>
            <pubDate>Sat, 28 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643289</guid>        </item>
        <item>
            <title>Commentary [Commentaries]</title>
            <link>http://www.medworm.com/index.php?rid=5643288&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F2%2F335-a%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643288</comments>
            <pubDate>Sat, 28 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643288</guid>        </item>
        <item>
            <title>A 14-Year-Old Boy with Chronic Cyanosis, Mild Anemia, and Limited Physical Resistance to Stress [Clinical Case Study]</title>
            <link>http://www.medworm.com/index.php?rid=5643286&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F2%2F332%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643286</comments>
            <pubDate>Sat, 28 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643286</guid>        </item>
        <item>
            <title>Newborn Screening for Metabolic Disorders: How Are We Doing, and Where Are We Going? [Q&amp;A]</title>
            <link>http://www.medworm.com/index.php?rid=5643285&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F2%2F324%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643285</comments>
            <pubDate>Sat, 28 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643285</guid>        </item>
        <item>
            <title>Breaking the Bottleneck in the Protein Biomarker Pipeline [Perspective]</title>
            <link>http://www.medworm.com/index.php?rid=5643284&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F2%2F321%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643284</comments>
            <pubDate>Sat, 28 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643284</guid>        </item>
        <item>
            <title>A Strong Start: Plasma Glial Fibrillary Acidic Protein and Stroke Differential Diagnosis [Editorial]</title>
            <link>http://www.medworm.com/index.php?rid=5643283&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F2%2F319%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643283</comments>
            <pubDate>Sat, 28 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643283</guid>        </item>
        <item>
            <title>William Harvey and the Undercurrents of Science [Science in the Arts]</title>
            <link>http://www.medworm.com/index.php?rid=5549324&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F317%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549324</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549324</guid>        </item>
        <item>
            <title>A Heart-to-Heart Talk [Unveiling the Right Side]</title>
            <link>http://www.medworm.com/index.php?rid=5549323&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F315%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549323</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549323</guid>        </item>
        <item>
            <title>In Reply [Letters to the Editor]</title>
            <link>http://www.medworm.com/index.php?rid=5549322&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F313%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549322</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549322</guid>        </item>
        <item>
            <title>High-Sensitivity Cardiac Troponin Assays--Change Is Important [Letters to the Editor]</title>
            <link>http://www.medworm.com/index.php?rid=5549321&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F311%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549321</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549321</guid>        </item>
        <item>
            <title>In Reply [Letters to the Editor]</title>
            <link>http://www.medworm.com/index.php?rid=5549320&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F309%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549320</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549320</guid>        </item>
        <item>
            <title>Copeptin--A Novel Marker in Acute Myocardial Infarction [Letters to the Editor]</title>
            <link>http://www.medworm.com/index.php?rid=5549319&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F307%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549319</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549319</guid>        </item>
        <item>
            <title>Copeptin Adds to High-Sensitivity Troponin T in Rapid Rule Out of Acute Myocardial Infarction [Letters to the Editor]</title>
            <link>http://www.medworm.com/index.php?rid=5549318&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F306%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549318</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549318</guid>        </item>
        <item>
            <title>Evidence-Based Laboratory Medicine: How Well Do Laboratories Follow Recommendations and Guidelines? The Cardiac Marker Guideline Uptake in Europe (CARMAGUE) Study [Letters to the Editor]</title>
            <link>http://www.medworm.com/index.php?rid=5549317&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F305%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549317</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549317</guid>        </item>
        <item>
            <title>Aspirin in the Primary Prevention of Myocardial Infarction [Citation Classic]</title>
            <link>http://www.medworm.com/index.php?rid=5549316&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F303%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549316</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549316</guid>        </item>
        <item>
            <title>Biomarkers for Predicting Serious Cardiac Outcomes at 72 Hours in Patients Presenting Early after Chest Pain Onset with Symptoms of Acute Coronary Syndromes [Brief Communications]</title>
            <link>http://www.medworm.com/index.php?rid=5549315&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F298%3Frss%3D1</link>
            <description>CONCLUSIONS:
The optimal cutoffs for predicting serious cardiac outcomes in this low-risk population are different from the published 99th percentiles. Larger studies are required to verify these findings. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549315</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549315</guid>        </item>
        <item>
            <title>Comparison of Midregional Pro-A-Type Natriuretic Peptide and the N-Terminal Pro-B-Type Natriuretic Peptide for Predicting Mortality and Cardiovascular Events [Brief Communications]</title>
            <link>http://www.medworm.com/index.php?rid=5549314&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F293%3Frss%3D1</link>
            <description>CONCLUSIONS:
MR-proANP was as efficient as NT-proBNP in predicting all-cause mortality, cardiovascular mortality, and cardiovascular events; however, its association with cardiovascular mortality was not independent from other confounders. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549314</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549314</guid>        </item>
        <item>
            <title>Troponin T Measurements by High-Sensitivity vs Conventional Assays for Risk Stratification in Acute Dyspnea [Proteomics and Protein Markers]</title>
            <link>http://www.medworm.com/index.php?rid=5549313&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F284%3Frss%3D1</link>
            <description>CONCLUSIONS:
hs-cTnT is associated with mortality in patients presenting with acute dyspnea. hs-cTnT concentrations provide additional prognostic information to cTnT and NT-proBNP testing in patients with cTnT concentrations below the detection limit. In particular, the hs-cTnT cutoff of 0.016 &amp;mu;g/L enables identification of low-risk patients. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549313</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549313</guid>        </item>
        <item>
            <title>Concordance, Variance, and Outliers in 4 Contemporary Cardiac Troponin Assays: Implications for Harmonization [Proteomics and Protein Markers]</title>
            <link>http://www.medworm.com/index.php?rid=5549312&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F274%3Frss%3D1</link>
            <description>CONCLUSIONS:
The universal definition of myocardial infarction should not depend on the choice of analyte or analyzer, and the between- and within-method differences described here need to be considered in the application of cardiac troponin in this respect. The variation between methods that cannot be explained by analytical imprecision and the discordant classification of results according to the respective 99th percentiles should be addressed. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549312</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549312</guid>        </item>
        <item>
            <title>Galectin-3 and the Development of Heart Failure after Acute Coronary Syndrome: Pilot Experience from PROVE IT-TIMI 22 [Proteomics and Protein Markers]</title>
            <link>http://www.medworm.com/index.php?rid=5549311&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F267%3Frss%3D1</link>
            <description>CONCLUSIONS:
The finding that galectin-3 is associated with the risk of developing HF following ACS adds to emerging evidence supporting galectin-3 as a biomarker of adverse remodeling contributing to HF as well as a potential therapeutic target. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549311</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549311</guid>        </item>
        <item>
            <title>Role of ST2 in Non-ST-Elevation Acute Coronary Syndrome in the MERLIN-TIMI 36 Trial [Proteomics and Protein Markers]</title>
            <link>http://www.medworm.com/index.php?rid=5549310&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F257%3Frss%3D1</link>
            <description>CONCLUSIONS:
ST2 correlates weakly with biomarkers of acute injury and hemodynamic stress but is strongly associated with the risk of HF after NSTE-ACS. This biomarker and related pathway merit further investigation as potential therapeutic targets for patients with ACS at risk for cardiac remodeling. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549310</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549310</guid>        </item>
        <item>
            <title>Markers of Plaque Instability in the Early Diagnosis and Risk Stratification of Acute Myocardial Infarction [Proteomics and Protein Markers]</title>
            <link>http://www.medworm.com/index.php?rid=5549309&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F246%3Frss%3D1</link>
            <description>CONCLUSIONS:
Biomarkers of plaque instability do not seem helpful in the early diagnosis of AMI but may provide some incremental value in the risk stratification of patients with acute chest pain. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549309</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549309</guid>        </item>
        <item>
            <title>Diagnostic Accuracy of Plasma Glial Fibrillary Acidic Protein for Differentiating Intracerebral Hemorrhage and Cerebral Ischemia in Patients with Symptoms of Acute Stroke [Proteomics and Protein Markers]</title>
            <link>http://www.medworm.com/index.php?rid=5549308&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F237%3Frss%3D1</link>
            <description>CONCLUSIONS:
Plasma GFAP analysis performed within 4.5 h of symptom onset can differentiate ICH and ischemic stroke. Studies are needed to evaluate a GFAP point-of-care system that may help optimize the prehospital triage and management of patients with symptoms of acute stroke. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549308</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549308</guid>        </item>
        <item>
            <title>Midregional Proadrenomedullin for Prediction of Cardiovascular Events in Coronary Artery Disease: Results from the AtheroGene Study [Proteomics and Protein Markers]</title>
            <link>http://www.medworm.com/index.php?rid=5549307&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F226%3Frss%3D1</link>
            <description>CONCLUSIONS:
MR-proADM is an independent predictor for future cardiovascular events in patients with symptomatic coronary artery disease, providing information comparable to NT-proBNP for secondary risk stratification. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549307</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549307</guid>        </item>
        <item>
            <title>Influence of Population Selection on the 99th Percentile Reference Value for Cardiac Troponin Assays [Proteomics and Protein Markers]</title>
            <link>http://www.medworm.com/index.php?rid=5549306&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F219%3Frss%3D1</link>
            <description>CONCLUSIONS:
The reference population selection strategy significantly influenced the 99th percentile reference values determined for troponin assays and the observed sex differences in troponin concentrations. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549306</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549306</guid>        </item>
        <item>
            <title>Absolute and Relative Kinetic Changes of High-Sensitivity Cardiac Troponin T in Acute Coronary Syndrome and in Patients with Increased Troponin in the Absence of Acute Coronary Syndrome [Proteomics and Protein Markers]</title>
            <link>http://www.medworm.com/index.php?rid=5549305&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F209%3Frss%3D1</link>
            <description>CONCLUSIONS:
Absolute changes appear superior to relative changes in discriminating non-STEMI. A rise or fall of at least 9.2 ng/L in the entire study population and 6.9 ng/L in selected ACS patients seems adequate to rule-out non-STEMI. However, -values are useful to rule-in non-STEMI only in a specific ACS population. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549305</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549305</guid>        </item>
        <item>
            <title>Circulating Troponin As Measured by a Sensitive Assay for Cardiovascular Risk Assessment in Primary Prevention [Lipids, Lipoproteins, and Cardiovascular Risk Factors]</title>
            <link>http://www.medworm.com/index.php?rid=5549304&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F200%3Frss%3D1</link>
            <description>CONCLUSIONS:
Minute increases in cTnI are associated with increased mortality and incident MACE in a large primary prevention cohort and, thus, identify contributors to cardiovascular risk not fully captured by traditional risk factor assessment. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549304</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549304</guid>        </item>
        <item>
            <title>Cystatin C and Estimated Glomerular Filtration Rate as Predictors for Adverse Outcome in Patients with ST-Elevation and Non-ST-Elevation Acute Coronary Syndromes: Results from the Platelet Inhibition and Patient Outcomes Study [Lipids, Lipoproteins, and Cardiovascular Risk Factors]</title>
            <link>http://www.medworm.com/index.php?rid=5549303&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F190%3Frss%3D1</link>
            <description>CONCLUSIONS:
Cystatin C concentration contributes independently in predicting the risk of cardiovascular death or myocardial infarction in NSTE-ACS, with no interaction by type of ACS. CKD-EPI exhibited the largest predictive value of all renal markers. Nevertheless, the additive predictive value of cystatin C or creatinine-based eGFR measures in the unselected ACS patient is small. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549303</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549303</guid>        </item>
        <item>
            <title>Rosuvastatin, Proprotein Convertase Subtilisin/Kexin Type 9 Concentrations, and LDL Cholesterol Response: the JUPITER Trial [Lipids, Lipoproteins, and Cardiovascular Risk Factors]</title>
            <link>http://www.medworm.com/index.php?rid=5549302&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F183%3Frss%3D1</link>
            <description>CONCLUSIONS:
In this randomized trial, rosuvastatin increased plasma concentration of PCSK9 in proportion to the magnitude of LDL-C reduction; the LDL-C response to statin could not be inferred by PCSK9 concentrations. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549302</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549302</guid>        </item>
        <item>
            <title>Association of Growth Differentiation Factor-15 with Coronary Atherosclerosis and Mortality in a Young, Multiethnic Population: Observations from the Dallas Heart Study [Lipids, Lipoproteins, and Cardiovascular Risk Factors]</title>
            <link>http://www.medworm.com/index.php?rid=5549301&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F172%3Frss%3D1</link>
            <description>CONCLUSIONS:
GDF-15 is independently associated with subclinical coronary atherosclerosis and mortality, and its potential role for risk stratification in the general population merits further evaluation. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549301</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549301</guid>        </item>
        <item>
            <title>Counterpoint: Standardization of Cardiac Troponin I Assays Will Not Occur in My Lifetime [Point/Counterpoint]</title>
            <link>http://www.medworm.com/index.php?rid=5549300&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F169%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549300</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549300</guid>        </item>
        <item>
            <title>Point: Put Simply, Standardization of Cardiac Troponin I Is Complicated [Point/Counterpoint]</title>
            <link>http://www.medworm.com/index.php?rid=5549299&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F165%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549299</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549299</guid>        </item>
        <item>
            <title>Counterpoint: Detection of Myocardial Infarction--Is It All Troponin? Role of New Markers [Point/Counterpoint]</title>
            <link>http://www.medworm.com/index.php?rid=5549298&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F162%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549298</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549298</guid>        </item>
        <item>
            <title>Point: Detection of Myocardial Infarction--Is It All Troponin? [Point/Counterpoint]</title>
            <link>http://www.medworm.com/index.php?rid=5549297&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F158%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549297</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549297</guid>        </item>
        <item>
            <title>Clopidogrel and CYP2C19 Testing: Ready for Clinical Prime Time? [Opinions]</title>
            <link>http://www.medworm.com/index.php?rid=5549296&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F154%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549296</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549296</guid>        </item>
        <item>
            <title>Are There Really Biomarkers of Vulnerable Plaque? [Opinions]</title>
            <link>http://www.medworm.com/index.php?rid=5549295&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F151%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549295</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549295</guid>        </item>
        <item>
            <title>Troponin Release--Reversible or Irreversible Injury? Should We Care? [Opinions]</title>
            <link>http://www.medworm.com/index.php?rid=5549294&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F148%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549294</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549294</guid>        </item>
        <item>
            <title>Metabolomics and Cardiovascular Biomarker Discovery [Reviews]</title>
            <link>http://www.medworm.com/index.php?rid=5549293&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F139%3Frss%3D1</link>
            <description>BACKGROUND:
Metabolomics, the systematic analysis of low molecular weight biochemical compounds in a biological specimen, has been increasingly applied to biomarker discovery.

CONTENT:
Because no single analytical method can accommodate the chemical diversity of the entire metabolome, various methods such as nuclear magnetic resonance spectroscopy (NMR) and mass spectrometry (MS) have been employed, with the latter coupled to an array of separation techniques including gas and liquid chromatography. Whereas NMR can provide structural information and absolute quantification for select metabolites without the use of exogenous standards, MS tends to have much higher analytical sensitivity, enabling broader surveys of the metabolome. Both NMR and MS can be used to characterize metabolite data...</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549293</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549293</guid>        </item>
        <item>
            <title>Emerging Biomarkers in Heart Failure [Reviews]</title>
            <link>http://www.medworm.com/index.php?rid=5549292&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F127%3Frss%3D1</link>
            <description>BACKGROUND:
Until recently, biomarker testing in heart failure (HF) syndromes has been viewed as an elective supplement to diagnostic evaluation of patients suspected to suffer from this condition. This approach to the use of biomarker testing contrasts with other cardiovascular diagnoses such as acute myocardial infarction, for which biomarkers are integral to disease process definition, risk stratification, and in some cases treatment decision making.

CONTENT:
In this review we consider various perspectives on the evaluation of biomarkers in HF. In addition, we examine recent advances in the understanding of established biomarkers in HF (such as the natriuretic peptides), the elucidation of novel biomarkers potentially useful for the evaluation and management of patients with HF, and th...</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549292</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549292</guid>        </item>
        <item>
            <title>Next Steps in Cardiovascular Disease Genomic Research--Sequencing, Epigenetics, and Transcriptomics [Reviews]</title>
            <link>http://www.medworm.com/index.php?rid=5549291&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F113%3Frss%3D1</link>
            <description>BACKGROUND:
Genomic research in cardiovascular disease (CVD) has progressed rapidly over the last 5 years. In most cases, however, these groundbreaking observations have not yet been accompanied by clinically applicable tools for risk prediction, diagnosis, or therapeutic interventions.

CONTENT:
We reviewed the scientific literature published in English for novel methods and promising genomic targets that would permit large-scale screening and follow-up of recent genomic findings for CVD. We anticipate that advances in 3 key areas will be critical for the success of these projects. First, exome-centered and whole-genome next-generation sequencing will identify rare and novel genetic variants associated with CVD and its risk factors. Improvements in methods will also greatly advance the fi...</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549291</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549291</guid>        </item>
        <item>
            <title>9p21 and the Genetic Revolution for Coronary Artery Disease [Reviews]</title>
            <link>http://www.medworm.com/index.php?rid=5549290&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F104%3Frss%3D1</link>
            <description>BACKGROUND:
It has long been recognized that 50% of the susceptibility for coronary artery disease (CAD) is due to predisposing genetic factors. Comprehensive prevention is likely to require knowledge of these genetic factors.

CONTENT:
Using a genomewide association study (GWAS), the Ottawa Heart Genomic Study and the deCODE group simultaneously identified the first genetic risk variant, at chromosome 9p21. The 9p21 variant became the first risk factor to be identified since 1964. 9p21 occurs in 75% of the population except for African Americans and is associated with a 25% increased risk for CAD with 1 copy and a 50% increased risk with 2 copies. Perhaps the most remarkable finding is that 9p21 is independent of all known risk factors, indicating there are factors contributing to the pat...</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549290</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549290</guid>        </item>
        <item>
            <title>Genomewide Association Studies in Cardiovascular Disease--An Update 2011 [Reviews]</title>
            <link>http://www.medworm.com/index.php?rid=5549289&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F92%3Frss%3D1</link>
            <description>BACKGROUND:
Genomewide association studies have led to an enormous boost in the identification of susceptibility genes for cardiovascular diseases. This review aims to summarize the most important findings of recent years.

CONTENT:
We have carefully reviewed the current literature (PubMed search terms: &quot;genome wide association studies,&quot; &quot;genetic polymorphism,&quot; &quot;genetic risk factors,&quot; &quot;association study&quot; in connection with the respective diseases, &quot;risk score,&quot; &quot;transcriptome&quot;).

SUMMARY:
Multiple novel genetic loci for such important cardiovascular diseases as myocardial infarction, hypertension, heart failure, stroke, and hyperlipidemia have been identified. Given that many novel genetic risk factors lie within hitherto-unsuspected genes or influence gene expression, these findings have ...</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549289</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549289</guid>        </item>
        <item>
            <title>B-Type Natriuretic Peptide: From Posttranslational Processing to Clinical Measurement [Reviews]</title>
            <link>http://www.medworm.com/index.php?rid=5549288&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F83%3Frss%3D1</link>
            <description>BACKGROUND:
Plasma cardiac natriuretic peptides and peptide fragments from their molecular precursors are markers of heart disease. Clinical studies have defined the current diagnostic utility of these markers, whereas biochemical elucidation of peptide structure and posttranslational processing has revealed new plasma peptide forms of potential clinical use.

CONTENT:
Natriuretic propeptide structures undergo variable degrees of endo- and exoproteolytic cleavages as well as amino acid modifications, which leave the plasma phase of the peptides highly heterogeneous and dependent on cardiac pathophysiology and capacity. An ongoing characterization of the molecular heterogeneity may not only help us to appreciate the biosynthetic capacity of the endocrine heart but may also lead to the disco...</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549288</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549288</guid>        </item>
        <item>
            <title>Biomarkers and Cardiovascular Risk Assessment for Primary Prevention: An Update [Reviews]</title>
            <link>http://www.medworm.com/index.php?rid=5549287&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F72%3Frss%3D1</link>
            <description>BACKGROUND:
Interest in cardiovascular biomarkers in primary prevention has increased dramatically in the past decade. This increase has been fueled by an improved understanding of cardiovascular pathophysiology, as well as novel technologies for biomarker identification.

CONTENT:
In this review we provide a brief overview of recent concepts in the evaluation of screening biomarkers, because biomarkers may behave differently when used for screening as opposed to diagnosis or disease staging. The following specific biomarker examples are then discussed, with a focus on data from primary prevention studies: high-sensitivity C-reactive protein, B-type natriuretic peptide, lipoprotein-associated phospholipase A2, and high-sensitivity troponin T. The article concludes by addressing novel platf...</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549287</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549287</guid>        </item>
        <item>
            <title>Use of Natriuretic Peptides to Guide and Monitor Heart Failure Therapy [Reviews]</title>
            <link>http://www.medworm.com/index.php?rid=5549286&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F62%3Frss%3D1</link>
            <description>BACKGROUND:
Plasma B-type cardiac natriuretic peptides reflect cardiac structure and function and have proven roles in assisting in the diagnosis of acute heart failure. They are independent prognostic indicators across the full spectrum of cardiovascular disease. Serial changes in plasma B-type cardiac natriuretic peptides parallel prognosis in chronic heart failure. Beneficial responses to medications and devices used in the treatment of heart failure are associated with decreases in plasma B-type peptide concentrations. This effect has led to the hypothesis that intensified treatment directed at reducing B-peptide concentrations may improve outcomes in heart failure.

CONTENT:
The efficacy of serial measurements of plasma B-type peptides in guiding titration of therapy for chronic heart...</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549286</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549286</guid>        </item>
        <item>
            <title>Analytical Characteristics of High-Sensitivity Cardiac Troponin Assays [Mini-Reviews]</title>
            <link>http://www.medworm.com/index.php?rid=5549285&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F54%3Frss%3D1</link>
            <description>BACKGROUND:
Cardiac troponins I (cTnI) and T (cTnT) have received international endorsement as the standard biomarkers for detection of myocardial injury, for risk stratification in patients suspected of acute coronary syndrome, and for the diagnosis of myocardial infarction. An evidence-based clinical database is growing rapidly for high-sensitivity (hs) troponin assays. Thus, clarifications of the analytical principles for the immunoassays used in clinical practice are important.

CONTENT:
The purpose of this mini-review is (a) to provide a background for the biochemistry of cTnT and cTnI and (b) to address the following analytical questions for both hs cTnI and cTnT assays: (i) How does an assay become designated hs? (ii) How does one realistically define healthy (normal) reference popu...</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549285</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549285</guid>        </item>
        <item>
            <title>Biomarkers in Cardiovascular Clinical Trials: Past, Present, Future [Mini-Reviews]</title>
            <link>http://www.medworm.com/index.php?rid=5549284&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F45%3Frss%3D1</link>
            <description>BACKGROUND:
Cardiovascular (CV) clinical trials are instrumental in understanding treatment effects and offer insights into the natural progression of CV disease. Biomarkers are a critical component of patient selection, end point definition, and safety monitoring, and clinical trials provide a platform for the discovery and validation of new biomarkers that may augment the understanding of disease mechanisms, risk stratification, and/or clinical decision-making.

CONTENT:
We review the roles that biomarkers have played in CV clinical trials and roles that CV clinical trials have played and will continue to play in the discovery and validation of biomarkers and their implementation in clinical practice. Large biobanks containing multiple specimen types are increasingly being created from p...</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549284</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549284</guid>        </item>
        <item>
            <title>Commentary [Commentaries]</title>
            <link>http://www.medworm.com/index.php?rid=5549283&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F44%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549283</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549283</guid>        </item>
        <item>
            <title>Interpreting Changes in Troponin--Clinical Judgment Is Essential [Clinical Case Study]</title>
            <link>http://www.medworm.com/index.php?rid=5549281&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F39%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549281</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549281</guid>        </item>
        <item>
            <title>The Challenges and Concerns Companies Face Pertaining to the US Food and Drug Administration 510(k) Process for Cardiac Biomarkers [Q&amp;A]</title>
            <link>http://www.medworm.com/index.php?rid=5549280&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F31%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549280</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549280</guid>        </item>
        <item>
            <title>Within Sight of a Rational Pipeline for Development of Protein Diagnostics [Perspectives]</title>
            <link>http://www.medworm.com/index.php?rid=5549279&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F28%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549279</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549279</guid>        </item>
        <item>
            <title>A Novel Technology for Measuring Cumulative Cardiac Biomarker Exposure over Time: What Happened When We Weren't Looking? [Perspectives]</title>
            <link>http://www.medworm.com/index.php?rid=5549278&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F25%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549278</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549278</guid>        </item>
        <item>
            <title>Reflections on the Evolution of Cardiac Biomarkers [Reflection]</title>
            <link>http://www.medworm.com/index.php?rid=5549277&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F21%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549277</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549277</guid>        </item>
        <item>
            <title>An Interview with Dr. Eugene Braunwald [Interview]</title>
            <link>http://www.medworm.com/index.php?rid=5549276&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F11%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549276</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549276</guid>        </item>
        <item>
            <title>Delta Cardiac Troponin Values in Practice: Are We Ready to Move Absolutely Forward to Clinical Routine? [Editorials]</title>
            <link>http://www.medworm.com/index.php?rid=5549275&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F8%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549275</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549275</guid>        </item>
        <item>
            <title>Statins, Plasma Proprotein Convertase Subtilisin/Kexin Type 9 Concentrations, and LDL Lowering [Editorials]</title>
            <link>http://www.medworm.com/index.php?rid=5549274&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F6%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549274</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549274</guid>        </item>
        <item>
            <title>Growth Differentiation Factor 15: A Canary in a Coal Mine? [Editorials]</title>
            <link>http://www.medworm.com/index.php?rid=5549273&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F3%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549273</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549273</guid>        </item>
        <item>
            <title>Impact of Biomarkers, Proteomics, and Genomics in Cardiovascular Disease [Introduction]</title>
            <link>http://www.medworm.com/index.php?rid=5549272&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F58%2F1%2F1%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5549272</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5549272</guid>        </item>
        <item>
            <title>On Chemistry, Scientists, and the Arts [International Year of Chemistry 2011]</title>
            <link>http://www.medworm.com/index.php?rid=5453655&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F12%2F1790%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5453655</comments>
            <pubDate>Mon, 28 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5453655</guid>        </item>
        <item>
            <title>Playing the Trumpet [Unveiling the Right Side]</title>
            <link>http://www.medworm.com/index.php?rid=5453654&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F12%2F1789%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5453654</comments>
            <pubDate>Mon, 28 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5453654</guid>        </item>
        <item>
            <title>The Personal Genome Machine--DNA Decoding with Semiconductors [Technology Corner]</title>
            <link>http://www.medworm.com/index.php?rid=5453653&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F12%2F1786%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5453653</comments>
            <pubDate>Mon, 28 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5453653</guid>        </item>
        <item>
            <title>&quot;Reaching Out to the World&quot; Appreciation [News &amp; Views]</title>
            <link>http://www.medworm.com/index.php?rid=5453652&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F12%2F1784%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5453652</comments>
            <pubDate>Mon, 28 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5453652</guid>        </item>
        <item>
            <title>Clinical Chemistry's Invited Reviewers 2011 [News &amp; Views]</title>
            <link>http://www.medworm.com/index.php?rid=5453651&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F12%2F1782%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5453651</comments>
            <pubDate>Mon, 28 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5453651</guid>        </item>
        <item>
            <title>Clinical Chemistry Trainee Council Advisory Board [News &amp; Views]</title>
            <link>http://www.medworm.com/index.php?rid=5453650&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F12%2F1781%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5453650</comments>
            <pubDate>Mon, 28 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5453650</guid>        </item>
        <item>
            <title>Call for Nominations [News &amp; Views]</title>
            <link>http://www.medworm.com/index.php?rid=5453649&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F12%2F1780%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5453649</comments>
            <pubDate>Mon, 28 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5453649</guid>        </item>
        <item>
            <title>An 83-Year-Old Woman with Discordant Urine Protein Results [What Is Your Guess?]</title>
            <link>http://www.medworm.com/index.php?rid=5453648&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F12%2F1779%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5453648</comments>
            <pubDate>Mon, 28 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5453648</guid>        </item>
        <item>
            <title>Correction [Correction]</title>
            <link>http://www.medworm.com/index.php?rid=5453647&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F12%2F1778%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5453647</comments>
            <pubDate>Mon, 28 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5453647</guid>        </item>
        <item>
            <title>Is the WHO 90:10 Prostate-Specific Antigen (PSA) First International Reference Standard Really 90% {alpha}1-Antichymotrypsin-Bound PSA and 10% Free PSA? [Letter to the Editor]</title>
            <link>http://www.medworm.com/index.php?rid=5453646&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F12%2F1776%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5453646</comments>
            <pubDate>Mon, 28 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5453646</guid>        </item>
        <item>
            <title>John Savory [Inspiring Minds]</title>
            <link>http://www.medworm.com/index.php?rid=5453645&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F12%2F1773%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5453645</comments>
            <pubDate>Mon, 28 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5453645</guid>        </item>
        <item>
            <title>Advances in the Clinical Staging of Chronic Lymphocytic Leukemia [Citation Classic]</title>
            <link>http://www.medworm.com/index.php?rid=5453644&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F12%2F1771%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5453644</comments>
            <pubDate>Mon, 28 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5453644</guid>        </item>
        <item>
            <title>Risk Prediction with Serial Myeloperoxidase Monitoring in Patients with Acute Chest Pain [Lipids, Lipoproteins, and Cardiovascular Risk Factors]</title>
            <link>http://www.medworm.com/index.php?rid=5453643&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F12%2F1762%3Frss%3D1</link>
            <description>CONCLUSIONS:
MPO concentrations are predictive of outcome up to 16 h after presentation with chest pain and predict events missed by cTnI testing, supporting a potential role in rapid patient triage. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5453643</comments>
            <pubDate>Mon, 28 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5453643</guid>        </item>
        <item>
            <title>C-Reactive Protein Induces Release of Both Endothelial Microparticles and Circulating Endothelial Cells In Vitro and In Vivo: Further Evidence of Endothelial Dysfunction [Lipids, Lipoproteins, and Cardiovascular Risk Factors]</title>
            <link>http://www.medworm.com/index.php?rid=5453642&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F12%2F1757%3Frss%3D1</link>
            <description>CONCLUSIONS:
We provide novel data that CRP, via NO deficiency, promotes endothelial dysfunction by inducing release of CECs and EMPs, which are biomarkers of endothelial dysfunction. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5453642</comments>
            <pubDate>Mon, 28 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5453642</guid>        </item>
        <item>
            <title>Urinary Excretion Kinetics of 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) and Its Phase I and Phase II Metabolites in Humans following Controlled MDMA Administration [Drug Monitoring and Toxicology]</title>
            <link>http://www.medworm.com/index.php?rid=5453641&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F12%2F1748%3Frss%3D1</link>
            <description>CONCLUSIONS:
Human MDMA urinary metabolites are primarily sulfates and glucuronides,with sulfates present in higher concentrations than glucuronides. Thisnew knowledge may lead to improvements in urine MDMA and metaboliteanalysis in clinical and forensic toxicology, particularly for theperformance of direct urine analysis. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5453641</comments>
            <pubDate>Mon, 28 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5453641</guid>        </item>
        <item>
            <title>The Need for Standardization of Tacrolimus Assays [Drug Monitoring and Toxicology]</title>
            <link>http://www.medworm.com/index.php?rid=5453640&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F12%2F1739%3Frss%3D1</link>
            <description>CONCLUSIONS:
Tacrolimus assay standardization will be necessary to compare patient results between clinical laboratories. Improved assay accuracy is required to provide optimized drug dosing and consistent care across transplant centers globally. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5453640</comments>
            <pubDate>Mon, 28 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5453640</guid>        </item>
        <item>
            <title>Simultaneous Detection of High-Sensitivity Cardiac Troponin I and Myoglobin by Modified Sandwich Lateral Flow Immunoassay: Proof of Principle [Point-of-Care Testing]</title>
            <link>http://www.medworm.com/index.php?rid=5453639&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F12%2F1732%3Frss%3D1</link>
            <description>CONCLUSIONS:
The described proof-of-principle LFIA method could be used as a point-of-care device in multiple protein quantification and semiquantitative analysis. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5453639</comments>
            <pubDate>Mon, 28 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5453639</guid>        </item>
        <item>
            <title>Altered Profile of Seminal Plasma MicroRNAs in the Molecular Diagnosis of Male Infertility [Molecular Diagnostics and Genetics]</title>
            <link>http://www.medworm.com/index.php?rid=5453638&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F12%2F1722%3Frss%3D1</link>
            <description>CONCLUSIONS:
The measurement of miRNAs in seminal plasma provides a novel, noninvasive approach for diagnosing male infertility. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5453638</comments>
            <pubDate>Mon, 28 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5453638</guid>        </item>
        <item>
            <title>Fifth-Generation Digital Immunoassay for Prostate-Specific Antigen by Single Molecule Array Technology [Cancer Diagnostics]</title>
            <link>http://www.medworm.com/index.php?rid=5453637&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F12%2F1712%3Frss%3D1</link>
            <description>CONCLUSIONS:
The robust 2-log improvement in limit of quantification relative to current ultrasensitive assays and the validated analytical performance of the assay allow for accurate assessment of PSA status after RP. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5453637</comments>
            <pubDate>Mon, 28 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5453637</guid>        </item>
        <item>
            <title>The Impact of Delayed Storage on the Measured Proteome and Metabolome of Human Cerebrospinal Fluid [Proteomics and Protein Markers]</title>
            <link>http://www.medworm.com/index.php?rid=5453636&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F12%2F1703%3Frss%3D1</link>
            <description>CONCLUSIONS:
The measured proteome and metabolome of centrifuged human CSF is stable at room temperature for up to 2 hours. We cannot exclude, however, that changes undetectable with our current methodology, such as denaturation or proteolysis, might occur because of sample handling conditions. The stability we observed gives laboratory personnel at the collection site sufficient time to aliquot samples before freezing and storage at &amp;ndash;80 &amp;deg;C. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5453636</comments>
            <pubDate>Mon, 28 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5453636</guid>        </item>
        <item>
            <title>Diabetes Antibody Standardization Program: First Proficiency Evaluation of Assays for Autoantibodies to Zinc Transporter 8 [Clinical Immunology]</title>
            <link>http://www.medworm.com/index.php?rid=5453635&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F12%2F1693%3Frss%3D1</link>
            <description>CONCLUSIONS:
The DASP workshop identified immunoprecipitation-based ZnT8A assays and antigen constructs that achieved both a high degree of sensitivity and specificity and were suitable for more widespread clinical application. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5453635</comments>
            <pubDate>Mon, 28 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5453635</guid>        </item>
        <item>
            <title>Long-Term Biological Variation of Serum Protein Electrophoresis M-Spike, Urine M-Spike, and Monoclonal Serum Free Light Chain Quantification: Implications for Monitoring Monoclonal Gammopathies [Clinical Immunology]</title>
            <link>http://www.medworm.com/index.php?rid=5453634&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F12%2F1687%3Frss%3D1</link>
            <description>CONCLUSIONS:
The variations in urine M-spike and serum FLC measurements during patient monitoring are similar and are larger than those for serum M-spikes. In addition, in this group of stable patients, a measurable serum FLC concentration was available twice as often as a measurable urine M-spike. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5453634</comments>
            <pubDate>Mon, 28 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5453634</guid>        </item>
        <item>
            <title>Prospective Registration of Marker Evaluation Studies: Time to Act [Opinions]</title>
            <link>http://www.medworm.com/index.php?rid=5453633&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F12%2F1684%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5453633</comments>
            <pubDate>Mon, 28 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5453633</guid>        </item>
        <item>
            <title>&quot;Research Use Only&quot; Reagents: Is There an Imperative for Increased FDA Oversight? [Opinions]</title>
            <link>http://www.medworm.com/index.php?rid=5453632&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F12%2F1681%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5453632</comments>
            <pubDate>Mon, 28 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5453632</guid>        </item>
        <item>
            <title>Proficiency Testing/External Quality Assessment: Current Challenges and Future Directions [Reviews]</title>
            <link>http://www.medworm.com/index.php?rid=5453631&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F12%2F1670%3Frss%3D1</link>
            <description>BACKGROUND:
Proficiency testing (PT), or external quality assessment (EQA), is intended to verify on a recurring basis that laboratory results conform to expectations for the quality required for patient care.

CONTENT:
Key factors for interpreting PT/EQA results are knowledge of the commutability of the samples used and the process used for target value assignment. A commutable PT/EQA sample demonstrates the same numeric relationship between different measurement procedures as that expected for patients' samples. Noncommutable PT/EQA samples frequently have a matrix-related bias of unknown magnitude that limits interpretation of results. PT/EQA results for commutable samples can be used to assess accuracy against a reference measurement procedure or a designated comparison method. In addi...</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5453631</comments>
            <pubDate>Mon, 28 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5453631</guid>        </item>
        <item>
            <title>Hepcidin in Human Iron Disorders: Diagnostic Implications [Reviews]</title>
            <link>http://www.medworm.com/index.php?rid=5453630&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F12%2F1650%3Frss%3D1</link>
            <description>We describe hepcidin structure, kinetics, function, and regulation. We moreover explore the therapeutic potential for modulating hepcidin expression and the diagnostic potential for hepcidin measurements in clinical practice.

SUMMARY:
Cell-culture, animal, and human studies have shown that hepcidin is predominantly synthesized by hepatocytes, where its expression is regulated by body iron status, erythropoietic activity, oxygen tension, and inflammatory cytokines. Hepcidin lowers serum iron concentrations by counteracting the function of ferroportin, a major cellular iron exporter present in the membrane of macrophages, hepatocytes, and the basolateral site of enterocytes. Hepcidin is detected in biologic fluids as a 25 amino acid isoform, hepcidin-25, and 2 smaller forms, i.e., hepcidin-...</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5453630</comments>
            <pubDate>Mon, 28 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5453630</guid>        </item>
        <item>
            <title>Commentary [Commentaries]</title>
            <link>http://www.medworm.com/index.php?rid=5453629&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F12%2F1649%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5453629</comments>
            <pubDate>Mon, 28 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5453629</guid>        </item>
        <item>
            <title>A 71-Year-Old Woman with Multiple Myeloma Status after Stem Cell Transplantation [Clinical Case Study]</title>
            <link>http://www.medworm.com/index.php?rid=5453627&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F12%2F1645%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5453627</comments>
            <pubDate>Mon, 28 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5453627</guid>        </item>
        <item>
            <title>Direct-to-Consumer Genetic Testing: Reliable or Risky? [Q&amp;A]</title>
            <link>http://www.medworm.com/index.php?rid=5453626&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F12%2F1641%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5453626</comments>
            <pubDate>Mon, 28 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5453626</guid>        </item>
        <item>
            <title>Whole-Genome Sequencing Informs Treatment: Personalized Medicine Takes Another Step Forward [Perspective]</title>
            <link>http://www.medworm.com/index.php?rid=5453625&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F12%2F1638%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5453625</comments>
            <pubDate>Mon, 28 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5453625</guid>        </item>
        <item>
            <title>Improved Monitoring of Differences in Serial Laboratory Results [Editorial]</title>
            <link>http://www.medworm.com/index.php?rid=5453624&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F12%2F1635%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5453624</comments>
            <pubDate>Mon, 28 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5453624</guid>        </item>
        <item>
            <title>William Cullen and Joseph Black: Chemistry, Medicine, and the Scottish Enlightenment [International Year of Chemistry 2011]</title>
            <link>http://www.medworm.com/index.php?rid=5373709&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F11%2F1632%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5373709</comments>
            <pubDate>Fri, 28 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5373709</guid>        </item>
        <item>
            <title>Humphry Davy and the Chemical Moment [International Year of Chemistry 2011]</title>
            <link>http://www.medworm.com/index.php?rid=5373708&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F11%2F1625%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5373708</comments>
            <pubDate>Fri, 28 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5373708</guid>        </item>
        <item>
            <title>The Beauty and Truth of the Citric Acid Cycle [Unveiling the Right Side]</title>
            <link>http://www.medworm.com/index.php?rid=5373707&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F11%2F1623%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5373707</comments>
            <pubDate>Fri, 28 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5373707</guid>        </item>
        <item>
            <title>Too Many Roads Not Taken in Biomarker Discovery: The Story of Missing Tools [News &amp; Views]</title>
            <link>http://www.medworm.com/index.php?rid=5373706&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F11%2F1621%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5373706</comments>
            <pubDate>Fri, 28 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5373706</guid>        </item>
        <item>
            <title>What Is Wrong with This Picture? [What is your Guess?]</title>
            <link>http://www.medworm.com/index.php?rid=5373705&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F11%2F1620%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5373705</comments>
            <pubDate>Fri, 28 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5373705</guid>        </item>
        <item>
            <title>Fast Separation of 25-Hydroxyvitamin D3 from 3-Epi-25-Hydroxyvitamin D3 in Human Serum by Liquid Chromatography-Tandem Mass Spectrometry: Variable Prevalence of 3-Epi-25-Hydroxyvitamin D3 in Infants, Children, and Adults [Letters to the Editor]</title>
            <link>http://www.medworm.com/index.php?rid=5373704&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F11%2F1618%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5373704</comments>
            <pubDate>Fri, 28 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5373704</guid>        </item>
        <item>
            <title>Long-Term Stability of Clinical Laboratory Data--Sodium as Benchmark [Letters to the Editor]</title>
            <link>http://www.medworm.com/index.php?rid=5373703&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F11%2F1616%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5373703</comments>
            <pubDate>Fri, 28 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5373703</guid>        </item>
        <item>
            <title>Profile of MicroRNAs Differentially Produced in Hearts from Patients with Hypertrophic Cardiomyopathy and Sarcomeric Mutations [Letters to the Editor]</title>
            <link>http://www.medworm.com/index.php?rid=5373702&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F11%2F1614%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5373702</comments>
            <pubDate>Fri, 28 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5373702</guid>        </item>
        <item>
            <title>Turning Catabolism into Usefulness--A Jaundiced View [Citation Classic]</title>
            <link>http://www.medworm.com/index.php?rid=5373701&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F11%2F1612%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5373701</comments>
            <pubDate>Fri, 28 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5373701</guid>        </item>
        <item>
            <title>Reference Values for Aldosterone-Renin Ratios in Normotensive Individuals and Effect of Changes in Dietary Sodium Consumption [Brief Communication]</title>
            <link>http://www.medworm.com/index.php?rid=5373700&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F11%2F1607%3Frss%3D1</link>
            <description>CONCLUSIONS:
We present reference values for the ARRprc for healthy individuals. The ARR is affected to a variable degree by sex and sodium intake. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5373700</comments>
            <pubDate>Fri, 28 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5373700</guid>        </item>
        <item>
            <title>Oral Fluid and Plasma Cannabinoid Ratios after Around-the-Clock Controlled Oral {Delta}9-Tetrahydrocannabinol Administration [Drug Monitoring and Toxicology]</title>
            <link>http://www.medworm.com/index.php?rid=5373699&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F11%2F1597%3Frss%3D1</link>
            <description>CONCLUSIONS:
OF monitoring does not reliably detect oral dronabinol intake. The time courses of THC and THCCOOH concentrations in plasma and OF were different after repeated oral THC doses, and high interindividual variation was observed. For these reasons, OF cannabinoid concentrations cannot predict concurrent plasma concentrations. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5373699</comments>
            <pubDate>Fri, 28 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5373699</guid>        </item>
        <item>
            <title>Motor Chip: A Comparative Genomic Hybridization Microarray for Copy-Number Mutations in 245 Neuromuscular Disorders [Molecular Diagnostics And Genetics]</title>
            <link>http://www.medworm.com/index.php?rid=5373698&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F11%2F1584%3Frss%3D1</link>
            <description>CONCLUSIONS:
The combination of exon-specific gene coverage and optimized platform and probe selection makes the Motor Chip a complementary tool for molecular diagnosis and gene investigation in neuromuscular diseases. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5373698</comments>
            <pubDate>Fri, 28 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5373698</guid>        </item>
        <item>
            <title>A New Functional CYP3A4 Intron 6 Polymorphism Significantly Affects Tacrolimus Pharmacokinetics in Kidney Transplant Recipients [Molecular Diagnostics and Genetics]</title>
            <link>http://www.medworm.com/index.php?rid=5373697&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F11%2F1574%3Frss%3D1</link>
            <description>CONCLUSIONS:
The CYP3A4 rs35599367C&amp;gt;T polymorphism is associated with a significantly altered Tac metabolism and therefore increases the risk of supratherapeutic Tac concentrations early after transplantation. Analysis of this CYP3A4*22 SNP may help in identifying patients at risk of Tac overexposure. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5373697</comments>
            <pubDate>Fri, 28 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5373697</guid>        </item>
        <item>
            <title>Investigating Interferences of a Whole-Blood Point-of-Care Creatinine Analyzer: Comparison to Plasma Enzymatic and Definitive Creatinine Methods in an Acute-Care Setting [Point-of-Care Testing]</title>
            <link>http://www.medworm.com/index.php?rid=5373696&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F11%2F1566%3Frss%3D1</link>
            <description>CONCLUSIONS:
These data suggest that whole-blood POC creatinine measurements should be used with caution. Negative interferences observed with these measurements could erroneously suggest adequate renal function near the decision threshold, particularly if estimated glomerular filtration rate is determined. Disparity between whole-blood and plasma matrices partially explains the discordance between whole-blood and plasma creatinine methods. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5373696</comments>
            <pubDate>Fri, 28 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5373696</guid>        </item>
        <item>
            <title>Fibulin-1 Is a Marker for Arterial Extracellular Matrix Alterations in Type 2 Diabetes [Endocrinology and Metabolism]</title>
            <link>http://www.medworm.com/index.php?rid=5373695&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F11%2F1556%3Frss%3D1</link>
            <description>CONCLUSIONS:
Fibulin-1 accumulates in the arterial wall and in plasma of patients with type 2 diabetes, and appears to be a factor associated with arterial extracellular matrix changes in type 2 diabetes. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5373695</comments>
            <pubDate>Fri, 28 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5373695</guid>        </item>
        <item>
            <title>High-Throughput Simultaneous Analysis of RNA, Protein, and Lipid Biomarkers in Heterogeneous Tissue Samples [General Clinical Chemistry]</title>
            <link>http://www.medworm.com/index.php?rid=5373694&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F11%2F1545%3Frss%3D1</link>
            <description>CONCLUSIONS:
The TMAD methodology described here enables semiautomated, high-throughput sampling of small amounts of heterogeneous tissue specimens by multiple analytical techniques with generally improved quality of recovered biomolecules. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5373694</comments>
            <pubDate>Fri, 28 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5373694</guid>        </item>
        <item>
            <title>Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases [Cancer Diagnostics]</title>
            <link>http://www.medworm.com/index.php?rid=5373693&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F11%2F1534%3Frss%3D1</link>
            <description>CONCLUSIONS:
HE4 has significantly higher diagnostic specificity than CA 125, and the combination of CA 125 and HE4 improved the detection of ovarian cancer in all stages and histological types. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5373693</comments>
            <pubDate>Fri, 28 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5373693</guid>        </item>
        <item>
            <title>Purified Anthocyanin Supplementation Improves Endothelial Function via NO-cGMP Activation in Hypercholesterolemic Individuals [Lipids, Lipoproteins, and Cardiovascular Risk Factors]</title>
            <link>http://www.medworm.com/index.php?rid=5373692&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F11%2F1524%3Frss%3D1</link>
            <description>CONCLUSIONS:
Anthocyanin supplementation improves endothelium-dependent vasodilation in hypercholesterolemic individuals. This effect involves activation of the NO-cGMP signaling pathway, improvements in the serum lipid profile, and decreased inflammation. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5373692</comments>
            <pubDate>Fri, 28 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5373692</guid>        </item>
        <item>
            <title>European Specialist Porphyria Laboratories: Diagnostic Strategies, Analytical Quality, Clinical Interpretation, and Reporting As Assessed by an External Quality Assurance Program [Evidence-Based Medicine and Test Utilization]</title>
            <link>http://www.medworm.com/index.php?rid=5373691&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F11%2F1514%3Frss%3D1</link>
            <description>CONCLUSIONS:
Based on a case-based EQA scheme, variations were apparent in analytical and diagnostic performance between European specialist porphyria laboratories. Our findings reinforce the use of EQA schemes as an essential tool to assess both analytical and diagnostic processes and thereby to improve patient care in rare diseases. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5373691</comments>
            <pubDate>Fri, 28 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5373691</guid>        </item>
        <item>
            <title>Specific Immunoassay Reveals Increased Serum Trypsinogen 3 in Acute Pancreatitis [Proteomics and Protein Markers]</title>
            <link>http://www.medworm.com/index.php?rid=5373690&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F11%2F1506%3Frss%3D1</link>
            <description>CONCLUSIONS:
We established for the first time a specific immunoassay for trypsinogen 3 using monoclonal antibodies. Patients with AP were found to have increased serum concentrations of trypsinogen 3. The availability of this assay will be useful for studies of the clinical utility of trypsinogen 3. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5373690</comments>
            <pubDate>Fri, 28 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5373690</guid>        </item>
        <item>
            <title>Carbamylation-Derived Products: Bioactive Compounds and Potential Biomarkers in Chronic Renal Failure and Atherosclerosis [Review]</title>
            <link>http://www.medworm.com/index.php?rid=5373689&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F11%2F1499%3Frss%3D1</link>
            <description>BACKGROUND:
Carbamylation is a posttranslational modification of proteins resulting from the nonenzymatic reaction between isocyanic acid and specific free functional groups. This reaction alters protein structural and functional properties and thus contributes to molecular ageing. Many studies have shown the involvement of carbamylated proteins in diseases, especially in chronic renal failure and atherosclerosis.

CONTENT:
In this review we describe the biochemical basis of the carbamylation process and its role in protein molecular ageing. We summarize the current evidence of protein carbamylation involvement in disease, identify available biomarkers of the carbamylation process and their related analytical methods, and discuss the practical relevance of these biomarkers.

SUMMARY:
Carba...</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5373689</comments>
            <pubDate>Fri, 28 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5373689</guid>        </item>
        <item>
            <title>Avoiding Pitfalls in Applying Prediction Models, As Illustrated by the Example of Prostate Cancer Diagnosis [Mini-Review]</title>
            <link>http://www.medworm.com/index.php?rid=5373688&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F11%2F1490%3Frss%3D1</link>
            <description>BACKGROUND:
The use of different mathematical models to support medical decisions is accompanied by increasing uncertainties when they are applied in practice. Using prostate cancer (PCa) risk models as an example, we recommend requirements for model development and draw attention to possible pitfalls so as to avoid the uncritical use of these models.

CONTENT:
We conducted MEDLINE searches for applications of multivariate models supporting the prediction of PCa risk. We critically reviewed the methodological aspects of model development and the biological and analytical variability of the parameters used for model development. In addition, we reviewed the role of prostate biopsy as the gold standard for confirming diagnoses. In addition, we analyzed different methods of model evaluation w...</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5373688</comments>
            <pubDate>Fri, 28 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5373688</guid>        </item>
        <item>
            <title>Commentary [Commentaries]</title>
            <link>http://www.medworm.com/index.php?rid=5373687&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F11%2F1489%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5373687</comments>
            <pubDate>Fri, 28 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5373687</guid>        </item>
        <item>
            <title>Unexplained Hemolytic Anemia with Multiorgan Failure [Clinical Case Study]</title>
            <link>http://www.medworm.com/index.php?rid=5373685&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F11%2F1485%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5373685</comments>
            <pubDate>Fri, 28 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5373685</guid>        </item>
        <item>
            <title>Circulating Cancer Cells and Their Clinical Applications [Q&amp;A]</title>
            <link>http://www.medworm.com/index.php?rid=5373684&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F11%2F1478%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5373684</comments>
            <pubDate>Fri, 28 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5373684</guid>        </item>
        <item>
            <title>FGF23: Is It Ready for Prime Time? [Perspectives]</title>
            <link>http://www.medworm.com/index.php?rid=5373683&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F11%2F1476%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5373683</comments>
            <pubDate>Fri, 28 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5373683</guid>        </item>
        <item>
            <title>SPINK1: A New Therapeutic Target in Cancer? [Perspectives]</title>
            <link>http://www.medworm.com/index.php?rid=5373682&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F11%2F1474%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5373682</comments>
            <pubDate>Fri, 28 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5373682</guid>        </item>
        <item>
            <title>In Search for a Better Marker of Acute Pancreatitis--Third Time Lucky? [Editorial]</title>
            <link>http://www.medworm.com/index.php?rid=5373681&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F11%2F1471%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5373681</comments>
            <pubDate>Fri, 28 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5373681</guid>        </item>
        <item>
            <title>International Year of Chemistry 2011: Berzelius, Liebig, and the Infrastructure of Chemistry [Clinical Chemist]</title>
            <link>http://www.medworm.com/index.php?rid=5267859&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F10%2F1468%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5267859</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5267859</guid>        </item>
        <item>
            <title>Unveiling the Right Side [Clinical Chemist]</title>
            <link>http://www.medworm.com/index.php?rid=5267858&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F10%2F1467%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5267858</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5267858</guid>        </item>
        <item>
            <title>News &amp; Views: Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease during Pregnancy and Postpartum [Clinical Chemist]</title>
            <link>http://www.medworm.com/index.php?rid=5267857&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F10%2F1466%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5267857</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5267857</guid>        </item>
        <item>
            <title>What Is Your Guess? Which Count Is Correct? [Clinical Chemist]</title>
            <link>http://www.medworm.com/index.php?rid=5267856&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F10%2F1465%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5267856</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5267856</guid>        </item>
        <item>
            <title>In Reply [Letters to the Editor]</title>
            <link>http://www.medworm.com/index.php?rid=5267855&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F10%2F1463-a%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5267855</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5267855</guid>        </item>
        <item>
            <title>The Consensus Statement on the Standardization and Evaluation of Growth Hormone and Insulin-like Growth Factor Assays Lacks a Recommendation to Attempt Efficacious Harmonization [Letters to the Editor]</title>
            <link>http://www.medworm.com/index.php?rid=5267854&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F10%2F1463%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5267854</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5267854</guid>        </item>
        <item>
            <title>Increased Serum Leptin Indicates Leptin Resistance in Obesity [Citation Classic]</title>
            <link>http://www.medworm.com/index.php?rid=5267853&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F10%2F1461%3Frss%3D1</link>
            <description>(Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5267853</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5267853</guid>        </item>
        <item>
            <title>Admission Proinsulin Is Associated with Mortality in Patients with Admission Hyperglycemia during Acute Coronary Syndrome: Results from a Pilot Observational Study [Brief Communications]</title>
            <link>http://www.medworm.com/index.php?rid=5267852&amp;cid=s_32068_59_f&amp;fid=32068&amp;url=http%3A%2F%2Fwww.clinchem.org%2Fcgi%2Fcontent%2Fshort%2F57%2F10%2F1456%3Frss%3D1</link>
            <description>CONCLUSIONS:
An increased proinsulin concentration may be a marker for mortality in ACS patients with hyperglycemia at admission and without known diabetes. Further studies are needed to evaluate the role of metabolic parameters such as proinsulin. (Source: Clinical Chemistry)</description>
            <author>Clinical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5267852</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5267852</guid>        </item>
    </channel>
</rss>

